Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 2/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.61 |
| ▸ | MMP2 | P08253 | 2/20 | 0.61 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.61 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.61 |
| ▸ | RAD52 | P43351 | 1/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5447356 | 0.98 | PSMD14 (0.63) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL5440695 | 0.98 | PSMD14 (0.63) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL31426886 | 0.95 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL31472851 | 0.95 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL28423912 | 0.95 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL9626985 | 0.95 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Phosphoric Acid SCHEMBL23151879 | 0.90 | PSMD14 (0.56) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL3862567 | 0.88 | PSMD14 (0.52) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL2912562 | 0.86 | PSMD14 (0.72) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL11227182 | 0.86 | PSMD14 (0.72) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3463584-B1 | THERAPEUTIC DENTAL PASTES AND THE APPLICATION THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20230293393-A1 | NATURAL TOOTH POWDER TABLETS | MCCORMICK LINDSAY (US) | 2023-09-21 | — | — | US | disclosed |
| US-11701306-B2 | Natural tooth powder tablets | MCCORMICK LINDSAY (US) | 2023-07-18 | — | — | US | disclosed |
| US-11696879-B2 | Therapeutic dental pastes and related methods and kits | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-07-11 | — | — | US | disclosed |
| US-20220211603-A1 | Oral Compositions And Methods Of Use | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2022-07-07 | — | — | US | disclosed |
| US-20220192953-A1 | Oral Compositions And Methods Of Use | 3M INNOVATIVE PROPERTIES COMPANY | 2022-06-23 | — | — | US | disclosed |
| CN-113840635-A | Oral compositions and methods of use | 3M创新有限公司 | 2021-12-24 | — | — | CN | disclosed |
| CN-113811282-A | Oral compositions and methods of use | 3M创新有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-109152936-B | Therapeutic toothpaste and related methods and kits | 3M创新有限公司 | 2021-08-27 | — | — | CN | disclosed |
| WO-2020234811-A1 | ORAL COMPOSITIONS AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-11-26 | — | — | WO | disclosed |
| EP-0297212-A2 | Oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-01-04 | — | — | EP | disclosed |
| US-4772461-A | LIQUID DENTIFRICES, MOUTHWASH; ANTICALCULUS | THE PROCTER & GAMBLE COMPANY (US) | 1988-09-20 | — | — | US | disclosed |
| US-4684518-A | ANTICALCULUS, PYROPHOSPHATE AND FLUORIDE | THE PROCTER & GAMBLE COMPANY (US) | 1987-08-04 | — | — | US | disclosed |
| US-4590066-A | DENTRIFRICE CONTAINING PYROPHOSPHATES | THE PROCTER & GAMBLE COMPANY (US) | 1986-05-20 | — | — | US | disclosed |
| US-4515772-A | ANTICARIES TOOTHPASTE | THE PROCTER & GAMBLE COMPANY (US) | 1985-05-07 | — | — | US | disclosed |
| US-4051234-A | BIS-GUANIDINE COMPOUND, ETHYLENEDIAMINEDIACETIC ACID OR SALT AS CHELATOR | THE PROCTER & GAMBLE COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
| US-4025616-A | Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies | THE PROCTER & GAMBLE COMPANY (US) | 1977-05-24 | — | — | US | disclosed |
| US-3959458-A | PHOSPHONATE OR AMINO-PHOSPHORUS COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
| US-3937807-A | BISBIGUANIDE COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1976-02-10 | — | — | US | disclosed |
| US-3934002-A | BIS-GUANIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696879-B2 | Therapeutic dental pastes and related methods and kits | PROC, DNASE1, COL2A1 | PSMD14 3985/4885PLA2G1B 1440/4885MMP2 58/4885 |
| US-20220211603-A1 | Oral Compositions And Methods Of Use | MSR1, GCK, TAS2R40 | PSMD14 2088/4885PLA2G1B 414/4885MMP2 2028/4885 |
| US-20220192953-A1 | Oral Compositions And Methods Of Use | HRH2, HRH3, HRH4 | PSMD14 2648/4885PLA2G1B 351/4885MMP2 3928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.